Dataset Information

HnRNPF extensively regulates expression and alternative splicing of genes associated with proliferation and migration in gastric cancer cells

ABSTRACT: Background: Heterogeneous nuclear ribonucleoprotein F (hnRNPF) is an RNA-binding protein (RBP) implicated in alternative splicing (AS) and tumorigenesis, yet its role in gastric cancer (GC) remains poorly defined. Methods: Here, we explored the expression pattern of hnRNPF in stomach adenocarcinoma (STAD) samples, and used small interference RNA to knockdown hnRNPF (si-hnRNPF) in AGS cells. Then we performed whole transcriptome sequencing method (RNA-seq) to investigate how hnRNPF modulates the expression and splicing landscape of GC cells. RT-qPCR experiment was used to validate the molecular targets of hnRNPF. Results: We found hnRNPF expression level was significantly increased in nodal metastasis status of GC patients by TCGA analysis, and was associated with the overall survival time of GC patients. By RNA-seq, we identified 929 differentially expressed genes (DEGs) and 2,669 hnRNPF-regulated AS events (RASEs). Functional enrichment revealed that hnRNPF-controlled DEGs were enriched in cell proliferation, extracellular-matrix organization, and immune-related pathways, which were tightly associated with GC progression. Notably, hnRNPF depletion significantly reduced the expression levels of CD55, CTGF, FZD5, KRT80, and TGM2. HnRNPF also significantly altered the splicing pattern of key GC-associated genes, including KRT80, CDC25B, CD151, DOK1, and ADAM15, which were validated by RT-qPCR and tightly associated with the prognosis result of GC patients. Conclusions: Collectively, our findings demonstrate that hnRNPF orchestrates the GC transcriptome at both transcriptional and post-transcriptional levels, positioning it as a potential therapeutic target for precision treatment of gastric cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE314680 | GEO | 2026/09/08

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Papillary thyroid cancer (PTC) is an ever-increasing cancer type worldwide, and greatly decreases the life quality and affects survival time of patients during its development and progression, but the underlying mechanisms and key factors for PTC progression are not clear. Recent studies demonstrated the potassium channel protein SK4, also named as KCNN4, participates in the progression of many cancers, while it lacks the molecular mechanism study for SK4 function. In this study, we performed functional and molecular explorations for SK4 by overexpressing its level in thyroid cancer BHT101 cells. Cellular proliferation and invasion experiments were performed to assess the influences of SK4 on cell behaviors. Further, whole transcriptome sequencing (RNA-seq) analysis helped us systematically investigated the down stream targets of SK4, including differentially expressed genes (DEGs) and regulated alternative splicing events (RASEs). We finally validated several DEGs and RASEs associated with the functions of SK4 by RT-qPCR experiment. In thyroid cancer patients, SK4 expression was completely lost in normal tissues and significantly increased in every stage of tumor tissues compared with normal tissues, the reason of which probably results from the low DNA methylation level at its promoter region. Consistent with previous study, SK4 overexpression (SK4-OE) promoted proliferation level and invasion ability of BHT10 cells compared with negative control (NC). By analyzing the RNA-seq data, we detected dozens of DEGs and found that up DEGs were enriched in negative regulation of apoptotic progress, including VTCN1, MSX1, FATE1, TEK, and PRAMEF2. More importantly, we found SK4-OE globally changed the alternative splicing pattern and identified 1639 RASEs. The genes of RASEs were enriched in DNA damage/repair, viral process, translation, and mRNA splicing pathways, which were tightly associated with the pathogenesis and progression of cancers. The splicing regulatory genes from RASGs could partly explain the reason of global AS dysregulation by SK4-OE in BHT101 cells. Finally, we validated several DEGs and RASEs associated with PTC progression by RT-qPCR. We found the expression of VTCN1, EDN1, SLC29A4, RP11-473M20.16, and CH507-513H4.4 were validated by RT-qPCR, as well as the AS pattern of TMEM116, RBM39, and RBM6. In summary, our results deeply explored the molecular targets of SK4 associated them with SK4-induced progression of PTC. We highlight that SE4-regulated AS pattern probably is a novel regulatory mechanism for SK4 in PTC. The identified DEGs and RASEs, as well as SK4 itself, could be used as potential therapeutic targets for PTC treatment in future.

Project description:Breast cancer has emerged as a prevalent form of cancer globally, particularly triple-negative breast cancer. The high prevalence and malignant characteristics of this condition are associated with a variety of environmental factors and molecular influences. Syntaxin Binding Protein 1 (STXBP1) is a transmembrane transport protein predominantly expressed in the brain, playing a crucial role in regulating neurotransmitter release. The low expression levels of STXBP1 are positively correlated with poor prognosis of breast cancer. However, the mechanisms by which STXBP1 contributes to the development of breast cancer remain unclear. In this study, we conducted an overexpression of STXBP1 in triple-negative breast cancer cells (MDA-MB-231) and subsequently assessed its impact on cellular characteristics. Following this, we employed transcriptome sequencing (RNA-seq) technology to investigate the downstream targets associated with STXBP1 overexpression. In MDA-MB-231 cells, the overexpression of STXBP1 significantly inhibited cell proliferation and enhanced apoptosis levels. Through an analysis of RNA sequencing data, we discovered that STXBP1 globally regulates both the expression and alternative splicing profile in MDA-MB-231 cells by modulating 111 differentially expressed genes (DEGs) and 1161 regulated alternative splicing events (RASEs). STXBP1 plays a crucial role in regulating the splicing patterns of numerous DNA repair-related genes, including USP48 and PLEC. Finally, we validated the expression changes of these genes and alternative splicing events in key pathways through RT-qPCR analysis. In addition, we conducted an overlap analysis on the transcriptome data of radiotherapy breast cancer cells alongside our own dataset, which revealed 21 differential alternative splicing events. Notably, this includes the DNA repair-related gene UBE21, whose expression patterns were corroborated by RT-qPCR experiments. We speculate that STXBP1 may play a role in the radiation resistance process of triple-negative breast cancer (TNBC) by regulating the alternative splicing of genes associated with DNA repair. To summarize, this study thoroughly investigated the downstream targets and functions of STXBP1 in breast cancer cells, elucidating the molecular mechanisms underlying STXBP1's anti-tumor properties in relation to breast cancer. These molecular targets have the potential to serve as promising avenues for the treatment of breast cancer, particularly in the case of triple-negative breast cancer.

Dataset Information

HnRNPF extensively regulates expression and alternative splicing of genes associated with proliferation and migration in gastric cancer cells

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets